Showing posts with label Ruchi Soya stock. Show all posts
Showing posts with label Ruchi Soya stock. Show all posts

Wednesday, 28 November 2018

HSBC ने शेयर बाजार में तेजी लौटने की जताई उम्मीद

एचएसबीसी ने भारतीय शेयर बाजार को लेकर अपने नजरिए में बदलाव किया है. एचएसबीसी ने क्षेत्रीय संदर्भ में अपने रुख को बदल कर 'कमजोर' से 'तटस्थ' कर दिया है. मॉर्गन स्टेनली और क्रेडिट सुईस के बाद भारतीय बाजार के लिए सकारात्मक रुझान देने वाली यह तीसरी फर्म है.


To Get Free Trial 
Missed call @ 8817002233 
Call Us @ 8822117117 
Mail Us = starindiamarket@gmail.com 
Visit = http://www.starindiaresearch.com/freetrail.php

Friday, 12 October 2018

YES Bank up 6% on appointment of advisory firm Korn Ferry to find new CEO

Shares of YES Bank have rallied 6% to Rs 255 on the BSE in early morning trade after the private sector lender appointed US-based headhunter Korn Ferry to assist the bank’s committee in its selection of the new managing director & chief executive officer (MD & CEO).


To Get Free Trial 
Missed call @ 9582541010 
Call Us @ 8822117117 
Mail Us = starindiamarket@gmail.com 
Visit = http://www.starindiaresearch.com/freetrail.php

Tuesday, 4 September 2018

L&T Infotech surges 7% on strong response for OFS

Shares of Larsen & Toubro (L&T) Infotech surged 7% to Rs 1,888 on the BSE in early morning trade on Tuesday after the company’s offer for sale (OFS) on Monday got a strong response from the institutional investors. The stock was trading close to its 52-week high of Rs 1,911 touched on August 21, 2018, on the BSE in intra-day trade. The share sale saw bids for 29.8 million shares as against 9.5 million on offer. The clearing price of Rs 1,751 fixed for non-retail bidding in L&T Infotech, the BSE data shows.


To Get Free Trial 
Missed call @ 9582541010 
Call Us @ 8822117117 
Mail Us = starindiamarket@gmail.com 
Visit = http://www.starindiaresearch.com/freetrail.php

Thursday, 16 August 2018

Sun Pharma hits 52-week high on USFDA approval, good Q1 results

Shares of Sun Pharmaceutical Industries hit its 52-week high of Rs 618, up 3% on the BSE in intra-day trade on Thursday, after the company announced that it has received approval for CEQUA from the U.S. Food and Drug Administration (FDA). CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).


To Get Free Trial 
Missed call @ 9582541010 
Call Us @ 8822117117 
Mail Us = starindiamarket@gmail.com 
Visit = http://www.starindiaresearch.com/freetrail.php

Tuesday, 14 August 2018

Ruchi Soya stock jumps after posting profit in Q1FY19

Shares of Ruchi Soya jumped 4.5% on the BSE in the morning trade after company posted Q1FY19 numbers. The company reported a net profit of Rs22.6cr for the quarter ended June 30. The company’s total income fell to Rs2,992.5cr in Q1FY19 from Rs3,280cr in the corresponding period of the previous year. Competition Commission of India (CCI) has approved the acquisition of Ruchi Soya by Adani Wilmar, as per media reports. Adani Wilmar had emerged as the highest bidder with an offer of about Rs6,000cr for Ruchi Soya, which is facing insolvency proceedings, report added.


To Get Free Trial 
Missed call @ 9582541010 
Call Us @ 8822117117 
Mail Us = starindiamarket@gmail.com 
 Visit = http://www.starindiaresearch.com/freetrail.php